With a $106.8 million strategy to tackle Africa's public health emergencies over the next five years, stakeholders here feel it will be an ideal opportunity for the Indian pharma companies to take advantage.
With a $106.8 million strategy to tackle Africa's public health emergencies over the next five years, stakeholders here feel it will be an ideal opportunity for the Indian pharma companies to take advantage.